Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
33 items
Children who slept near a cooking fire were four times as likely to develop severe trachoma compared with children who slept in ventilated rooms without cooking fires. This child’s severe trachoma led to loss of vision in his left eye. Photo courtesy of Raul Vasquez/Orbis.

Trachoma Risk Tied to Sleeping Near Cooking Fires, Lack of Ventilation

Children who sleep in unventilated rooms with cooking fires are at greater risk for severe trachoma, a leading cause of preventable blindness in developing countries.
Ebola virus, isolated in November 2014 from patient blood samples obtained in Mali. The virus was isolated on Vero cells in a BSL-4 suite at NIAID Rocky Mountain Laboratories. Credit: NIAID

Study of Ebola Survivors Opens in Liberia

The Liberia-U.S. clinical research partnership known as PREVAIL has launched a study of people in Liberia who have survived Ebola virus disease (EVD) within the past two years.
Grantee News

Patients with AIDS at Increased Risk of Developing Age-Related Macular Degeneration

Patients with acquired immunodeficiency syndrome (AIDS) have a four-fold increase in their risk of developing intermediate-stage age-related macular degeneration (AMD) compared to people of the same age who are not infected with HIV.
National Eye Institute logo.

Antibiotic Effective Against Leading Cause of Blindness Throughout the World

A clinical trial funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), has concluded that a single dose of azithromycin taken by mouth after surgery reduces by one-third the recurrence of a vision-threatening...
National Eye Institute logo.

Eye Surgery on Histoplasmosis Lesions Provides Limited Benefits

For most patients with abnormal blood vessels in the eye, either as a delayed complication from a fungus infection called histoplasmosis or from unknown causes, surgery will not likely improve vision.
National Eye Institute logo.

Anti-HIV Treatment Improves Immune System and Fights Sight-Threatening Eye Infection

A combination of anti-HIV drugs appears to help rejuvenate the immune systems of people with AIDS and prevent progression of cytomegalovirus (CMV) retinitis, a potentially blinding AIDS-related eye complication.
National Eye Institute logo.

Antiviral Drug Sharply Reduces Return of Herpes of the Eye

Researchers have found that an antiviral drug, often used to suppress genital herpes, also decreases the recurrence of herpes of the eye. A paper detailing these findings is published in the July 30, 1998 issue of The New England Journal of Medicine
National Eye Institute logo.

Combination Drug Therapy for AIDS Found to Control Blinding Eye Infection

Researchers at the National Institutes of Health have discovered that a combination of protease inhibitors and other anti-HIV drugs used to treat people with AIDS
National Eye Institute logo.

NIH-Sponsored Study Stopped: New Drug Does Not Control AIDS-Related Eye Disease

Researchers have stopped patient enrollment and treatment in a studydesigned to evaluate the safety and effectiveness of a new drug totreat a blinding eye infection common in people with AIDS.
National Eye Institute logo.

Two Drug Treatment Is Effective Against Recurrent Eye Infection In AIDS Patients

A combination of two antiviral drugs is more effective than either drug alone for controlling recurrences of a blinding eye infection common in people with AIDS, according to new clinical trial results from a federally-sponsored study.

Want more news from NEI?

Subscribe to our news feed to stay up to date on vision and eye health research!

Success! Link copied to clipboard.

Copy to clipboard failed.

You can also browse older stories in our news archive

NEI Press Office

We can connect media professionals with the latest vision research info. Get in touch!


Phone: 301-496-5248